Brief: Lee's Pharmaceutical Holdings Says Co Decides To Implement Share Repurchase Program Of Up To 30 Mln Shares
02/09/2019 14:31
Sept 2 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* CO DECIDED TO IMPLEMENT A SHARE REPURCHASE PROGRAM OF UP
TO 30
MILLION SHARES
* LEE'S PHARMACEUTICAL - AGGREGATE AMOUNT OF FUNDS INTENDED
TO BE
USED FOR PROPOSED SHARE REPURCHASE UP TO HK$120 MILLION
Source text for Eikon: ID:nHKS1nmLLg
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals